drugset
Drugs / Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
last change Aug 2014 re-read 3 minutes ago

Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed

also known as BK1301

Vaccine

Developed for
diphtheria · pertussis · tetanus
Investigated by
Tanabe Pharma Corporation · The Research Foundation for Microbial Diseases of Osaka University

Trials 1

today NCT02118961 · Ph 3
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02118961 Apr → Aug 2014 diphtheria, pertussis, tetanus Tanabe Pharma Corporation Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed ClinicalTrials.gov intervention name — accepted as the source's own label NCT02118961 ↗
Known as BK1301 “Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301)” NCT02118961 ↗
Modality Vaccine “DTaP vaccine (BK1301)” NCT02118961 ↗
Route Subcutaneous “subcutaneous injection” NCT02118961 ↗